FTC says pharmacy benefits managers marked-up drug prices for $7.3bn gain

Regulator’s report finds companies ‘hiked costs’ for a range of medicines, including cancer and HIV treatments

Bureau Veritas in talks with rival SGS to create €32bn specialist in testing